2011 Update on Radioimmunotherapy in the Treatment of Lymphoma

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Saturday, June 4 | 4:30 PM - 6:00 PM
Ballroom C2

Upon completion of this activity, the participant will be able to:
1. Apply 2011 appropriateness criteria for selection of patients for radioimmunotherapy (RIT).
2. Choose the most appropriate type of RIT for his or her patients.
3. Discuss the most recent comparative effectiveness studies comparing RIT with immunotherapy and chemotherapy.

Speakers are:
Michael L. Goris, MD, PhD, Stanford University Medicine Center in Stanford, Calif.;
Erik S. Mittra, MD, PhD, Stanford University Medical Center in Stanford, Calif.; and
Andrei Horia Iagaru, MD, Lucile Packard Children's Hospital in Stanford, Calif.